Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
about
Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Combined treatment with dipept ...... rat model of steatohepatitis.
@en
Combined treatment with dipeptidyl peptidase-4 inhibitor
@nl
type
label
Combined treatment with dipept ...... rat model of steatohepatitis.
@en
Combined treatment with dipeptidyl peptidase-4 inhibitor
@nl
prefLabel
Combined treatment with dipept ...... rat model of steatohepatitis.
@en
Combined treatment with dipeptidyl peptidase-4 inhibitor
@nl
P2093
P2860
P356
P1433
P1476
Combined treatment with dipept ...... c rat model of steatohepatitis
@en
P2093
Hideto Kawaratani
Hiroaki Takaya
Hitoshi Yoshiji
Kei Moriya
Keisuke Nakanishi
Kenichiro Seki
Kiyoshi Asada
Kosuke Kaji
Kosuke Takeda
Masanori Furukawa
P2860
P304
P356
10.1111/HEPR.12860
P577
2017-02-13T00:00:00Z